Neuhaus T J, Burger H R, Klingler M, Fanconi A, Leumann E P
University Children's Hospital, Zürich, Switzerland.
Eur J Pediatr. 1992 Oct;151(10):775-8. doi: 10.1007/BF01959089.
Therapy of steroid-dependent idiopathic nephrotic syndrome is often unsatisfactory. Since 1986 we have treated nine children (six male and three female), aged 3-16 years, with cyclosporin A (CsA) during 2.0-5.2 (median 3.1) years. All had minimal change disease on renal biopsy and had previously received cyclophosphamide. Mean daily dosage of CsA was 4.1 mg/kg (range 2.7-5.8) and mean whole blood trough level was 220 ng/ml (range 141-271). The relapse rate decreased from 3.4/patient year before CsA to 0.55 on CsA. Discontinuation of CsA or reduction below 2 mg/kg daily was always followed by a relapse. The overall relapse rate, including the period with very low-dose CsA, was 0.95/patient year. Four patients required additional low-dose alternate-day prednisone. Repeat renal biopsy showed minimal change disease in eight patients and focal segmental glomerulosclerosis in one; CsA-toxicity was mild in two and moderate in one. The latter was the only patient with slightly reduced glomerular filtration rate. Two boys with delayed puberty spontaneously matured and reached expected final height. We conclude that long-term low-dose CsA is very effective and steroid-sparing. Its use is justified in selected patients, particularly in those with numerous relapses and in male patients before and during puberty, as long as renal function and CsA-toxicity are carefully monitored.
类固醇依赖型特发性肾病综合征的治疗效果往往不尽人意。自1986年以来,我们对9名年龄在3至16岁的儿童(6名男性和3名女性)使用环孢素A(CsA)进行了2.0至5.2年(中位时间为3.1年)的治疗。所有患儿肾活检均为微小病变型,且此前均接受过环磷酰胺治疗。CsA的平均日剂量为4.1mg/kg(范围为2.7至5.8mg/kg),全血谷浓度平均为220ng/ml(范围为141至271ng/ml)。复发率从使用CsA前的3.4次/患者年降至使用CsA后的0.55次/患者年。停用CsA或将剂量降至每日2mg/kg以下后总会复发。包括极低剂量CsA治疗期在内的总复发率为0.95次/患者年。4名患者需要额外使用小剂量隔日泼尼松。重复肾活检显示,8名患者为微小病变型,1名患者为局灶节段性肾小球硬化;2名患者CsA毒性轻微,1名患者为中度。后者是唯一一名肾小球滤过率略有降低的患者。两名青春期延迟的男孩自发成熟并达到预期最终身高。我们得出结论,长期低剂量CsA非常有效且能减少类固醇的使用。在经过挑选的患者中,尤其是那些复发频繁的患者以及青春期前和青春期的男性患者中,只要仔细监测肾功能和CsA毒性,使用CsA是合理的。